Tenaya Therapeutics faces direct competition within the specialized cardiovascular gene therapy and biopharmaceutical sector from clinical-stage enterprises and genetic medicine developers creating treatments for heart conditions and inherited cardiomyopathies. Competitors include companies such as 4D Molecular Therapeutics, Silence Therapeutics, and various specialized cardiovascular-focused genetic medicine firms.